The JOURNAL OF ORTHOPAEDIC RESEARCH, published by WILEY, stands as a premier peer-reviewed journal in the field of orthopedics and sports medicine, showcasing high-impact research with a notable impact factor and categorized in the top Q1 quartile for 2023. Since its inception in 1983, this journal has continuously evolved to meet the needs of a dynamic scientific community, serving as a vital resource for researchers, clinicians, and students engaged in the study and practice of orthopedics. With commendable rankings, positioned at Rank #47 out of 321 in the Medicine Orthopedics and Sports Medicine category, and boasting a remarkable 85th percentile in Scopus rankings, it highlights groundbreaking studies and advances in orthopedic science. While not an open-access journal, it provides diverse access options to ensure that its contributions are available to a broad academic audience. The journal plays a crucial role in disseminating innovative ideas and fostering collaboration within the orthopedic research community, thereby promoting improved patient care and outcomes in musculoskeletal health.

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

MEDICAL ENGINEERING & PHYSICS, published by Elsevier Science Ltd, is an esteemed journal in the fields of Biomedical Engineering and Biophysics. With an ISSN of 1350-4533 and an E-ISSN of 1873-4030, it has established itself as a significant resource from its inception in 1994, continuing to deliver pivotal research up to 2024. This journal, categorized in the Q3 quartile for both Biomedical Engineering and Biophysics, holds a respectable position in Scopus rankings, boasting its relevance in the upper echelons of academic inquiry, particularly ranking #75/152 in Biophysics and #158/303 in Biomedical Engineering. Authors and researchers in these dynamic fields will find the journal’s rigorous peer-review process and commitment to publishing high-quality original research invaluable for advancing their work. Although the journal is not open access, it continues to attract submissions that push the boundaries of innovation and application in medical technologies, making it an essential resource for anyone dedicated to the integration of engineering principles with medical sciences.

Biomedical Engineering Letters, published by SpringerNature, is a prominent journal in the field of Biomedical Engineering. With a robust ISSN of 2093-9868 and E-ISSN of 2093-985X, this esteemed journal has established itself as a vital resource for researchers and professionals seeking to advance their knowledge and share groundbreaking findings. Recognized for its quality, Biomedical Engineering Letters holds a distinguished ranking in Scopus, positioned at #94/303 (69th percentile) in the Biomedical Engineering category. The journal covers a diverse scope within biomedical engineering, providing an important platform for innovative research from 2011 to 2024 and facilitating the exchange of ideas among scholars. Although it operates under a subscription model, the journal's commitment to enhancing the field makes it an indispensable reference for those engaged in cutting-edge biomedical research in Germany and globally.

Bone & Joint Research is a prestigious open access journal published by the British Editorial Society of Bone & Joint Surgery, which has been serving the orthopedic and surgical community since its inception in 2012. With an impact factor reflecting its high standards and relevance within the field, this journal boasts impressive Scopus rankings, positioning it in the Q1 category for both Orthopedics and Sports Medicine and Surgery as of 2023. Located in the United Kingdom, the journal aims to disseminate cutting-edge research, clinical studies, and innovative approaches to treatment in musculoskeletal health, making it an indispensable resource for researchers, healthcare professionals, and students alike. The journal encourages a collaborative discourse that fosters advancements in the understanding and treatment of bone and joint diseases, fulfilling its mission to enhance patient outcomes and improve the quality of care.

Welcome to the Journal of Orthopaedic Surgery and Research, a leading platform for disseminating innovative findings in the field of orthopaedic surgery and its related disciplines. Published by BMC, this esteemed journal has been an Open Access resource since 2006, ensuring that critical research is freely accessible to the global scientific community. Operating from the United Kingdom, the journal has achieved impressive rankings, placing in the Q2 category for Orthopedics and Sports Medicine and Q1 for Surgery in 2023. With its rigorous peer-review process and commitment to quality, it ranks 129th out of 551 in the Surgery category and 102nd out of 321 in Orthopedics and Sports Medicine on Scopus, reflecting its high impact and relevance. The journal covers a broad range of topics within the field, including clinical studies, surgical techniques, and rehabilitation, making it an essential resource for researchers, practitioners, and students seeking to advance their knowledge and contribute to the evolving landscape of orthopaedic medicine.

Advanced Biomedical Research, published by Wolters Kluwer Medknow Publications, is a prominent open access journal dedicated to advancing the field of biomedical research since its inception in 2012. With an ISSN of 2277-9175, this journal serves as a vital platform for researchers, professionals, and students to disseminate high-quality research findings and innovative ideas in a variety of topics within biochemistry, genetics, and molecular biology. Recognized within the Q3 category of the 2023 journal quartile rankings, it ranks 365th among general medicine journals and 187th in the general fields of biochemistry and genetics, underscoring its commitment to fostering scientific dialogue and collaboration. With its open access model, Advanced Biomedical Research ensures that research is readily accessible to a global audience, thereby enhancing the visibility and impact of scholarly work. As the journal continues to evolve through its converged editorial focus from 2019 to 2024, it aims to play a critical role in shaping the future of biomedical sciences in India and beyond.

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.